Transarterial chemoembolization and selective internal radiation for the treatment of patients with metastatic neuroendocrine tumors: A comparison of efficacy and cost

Oncologist

Volumn 16, Issue 5, 2011, Pages 594-601

  Whitney, Ryan ^a   Vàlek, Vlatimil ^b   Fages, Joan Falco ^c   Garcia, Agustin ^d   Narayanan, Govindarajan ^e   Tatum, Cliff ^f   Hahl, Mike ^g   Martin II, Robert C G ^a  

^a University of Louisville School of Medicine   (United States)

^b MASARYK UNIVERSITY   (Czech Republic)

^c Hospital Parc Taulí de Sabadell   (Spain)

^d HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^e UNIVERSITY OF MIAMI   (United States)

^f Norton Radiology   (United States)

^g Norton Cancer Institute   (United States)

Author keywords

Chemoembolization; Doxorubicin; Liver directed therapy; Metastatic neuroendocrine; Yttrium 90

Indexed keywords

ALBUMIN TC 99M; DOXORUBICIN; MICROSPHERE; YTTRIUM 90;

ADULT; AGED; ANOREXIA; BLEEDING; CANCER RADIOTHERAPY; CHEMOEMBOLIZATION; CLINICAL ARTICLE; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; DRUG COST; FEMALE; FOLLOW UP; HEALTH CARE COST; HEMATOLOGIC DISEASE; HUMAN; HYPERTENSION; INSTITUTIONAL REVIEW; LIVER FAILURE; LIVER METASTASIS; MALE; METASTASIS POTENTIAL; MULTICENTER STUDY; NAUSEA; NEUROENDOCRINE TUMOR; OVERALL SURVIVAL; PAIN; PANCREATITIS; PATIENT MONITORING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION SAFETY; REVIEW; SELECTIVE INTERNAL RADIATION THERAPY; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR VOLUME; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; CHEMOEMBOLIZATION, THERAPEUTIC; COMBINED MODALITY THERAPY; COST-BENEFIT ANALYSIS; DOXORUBICIN; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEUROENDOCRINE TUMORS; TREATMENT OUTCOME; YTTRIUM RADIOISOTOPES;

EID: 79959189075     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2010-0292     Document Type: Review

References (16)

1. Kulke MH. New developments in the treatment of gastrointestinal neuroendocrine tumors. Curr Oncol Rep 2007;9:177-183.
2. Sacks D, Marinelli DL, Martin LG et al. General principles for evaluation of new interventional technologies and devices. J Vasc Interv Radiol 2003; 14:S391-S394.
3. Levine MN, Julian JA. Registries that show efficacy: Good, but not good enough. J Clin Oncol 2008;26:5316-5319.
4. Whitney R, Tatum C, Hahl M et al. Safety of hepatic resection in metastatic disease to the liver after yttrium-90 therapy. J Surg Res 2011;166:236-240.
5. Martin RC, Joshi J, Robbins K et al. Transarterial chemoembolization of metastatic colorectal carcinoma with drug-eluting beads, irinotecan (DEBIRI): Multi-institutional registry. J Oncol 2009;2009:539795.
6. Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer 2003;97:934-959.
7. Landry CS, Scoggins CR, McMasters KM et al. Management of hepatic metastasis of gastrointestinal carcinoid tumors. J Surg Oncol 2008;97:253-258.
8. Lien WM, Ackerman NB. The blood supply of experimental liver metastases. II. A microcirculatory study of the normal and tumor vessels of the liver with the use of perfused silicone rubber. Surgery 1970;68:334-340.
9. Ridge JA, Bading JR, Gelbard AS et al. Perfusion of colorectal hepatic metastases. Relative distribution of flow from the hepatic artery and portal vein. Cancer 1987;59:1547-1553.
10. Pitt SC, Knuth J, Keily JM et al. Hepatic neuroendocrine metastases: Chemo-or bland embolization? J Gastrointest Surg 2008;12:1951-1960.
11. Brown KT, Koh BY, Brody LA et al. Particle embolization of hepatic neuroendocrine metastases for control of pain and hormonal symptoms. J Vasc Interv Radiol 1999;10:397-403.
12. de Baere T, Deschamps F, Teriitheau C et al. Transarterial chemoembolization of liver metastases from well differentiated gastroenteropancreatic endocrine tumors with doxorubicin-eluting beads: Preliminary results. J Vasc Interv Radiol 2008;19:855-861.
13. 90Y Radioembolization for metastatic neuroendocrine liver tumors: Preliminary results from a multiinstitutional experience. Ann Surg 2008;247:1029-1035.
14. 90Y-microspheres: Early results in 148 patients. Am J Clin Oncol 2008;31:271-279.
15. Schell SR, Camp ER, Caridi JG et al. Hepatic artery embolization for control of symptoms, octreotide requirements, and tumor progression in metastatic carcinoid tumors. J Gastrointest Surg 2002;6:664-670.
16. Bloomston M, Al-Saif O, Klemanski D et al. Hepatic artery chemoembolization in 122 patients with metastatic carcinoid tumor: Lessons learned. J Gastrointest Surg 2007;11:264-271.